Nature Reviews Drug Discovery
| Nature Reviews Drug Discovery
|
|
|---|---|
| description | Peer-reviewed journal |
| Area of Expertise | Pharmacology , pharmacy and medicine |
| language | English |
| publishing company | NPG ( United Kingdom ) |
| First edition | 2002 |
| Frequency of publication | 12 / year |
| editor | Peter Kirkpatrick |
| Web link | Website of the journal |
| ISSN (print) | 1474-1776 |
Nature Reviews Drug Discovery , abbreviated Nat. Rev. Drug Discov. , is a professional journal published by the Nature Publishing Group . The first edition appeared in January 2002. Currently (as of 2012) twelve editions are published each year. The journal publishes reviews in the areas of drug discovery and drug development. The following topics are considered:
- Discovery of target structures
- Rational drug design
- Combinatorial and parallel synthesis
- Medicinal chemistry
- Classes of key compounds
- Natural products
- High throughput screening
- Novel therapeutic approaches for disease states
- Microarrays
- Bioinformatics
- Absorption , distribution , metabolism and elimination
- Pharmacokinetics and pharmacodynamics
- pharmacology
- toxicology
- Pharmacogenomics and Toxicogenomics
- Drug release
- biotechnology
- Vaccines
- Evaluation of clinical studies
- Regulatory things
- Pharmacoeconomics
The journal's impact factor in 2014 was 41,908. According to the statistics of the ISI Web of Knowledge , the journal with this impact factor ranks first out of 162 journals in the biotechnology and applied microbiology category and first out of 254 journals in the pharmacology and pharmacy category.
The editor-in-chief is Peter Kirkpatrick , who is employed by the publisher.
Web links
Individual evidence
- ↑ a b website of the journal at the NPG publishing house ; Retrieved November 11, 2012.
- ↑ 2014 Journal Citation Reports Science Edition (Thomson Reuters, 2015).